Magnesium Sulfate as a Second-Line Tocolytic Agent for Preterm Labor: A Randomized Controlled Trial in Kyushu Island

Objectives. We evaluated the efficacy of magnesium sulfate as a second-line tocolysis for 48 hours. Materials and Methods. A multi-institutional, simple 2-arm randomized controlled trial was performed. Forty-five women at 22 to 34 weeks of gestation were eligible, whose ritodrine did not sufficientl...

Full description

Saved in:
Bibliographic Details
Main Authors: Yasuyuki Kawagoe, Hiroshi Sameshima, Tsuyomu Ikenoue, Ichiro Yasuhi, Tatsuhiko Kawarabayashi
Format: Article
Language:English
Published: Wiley 2011-01-01
Series:Journal of Pregnancy
Online Access:http://dx.doi.org/10.1155/2011/965060
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1841524645022400512
author Yasuyuki Kawagoe
Hiroshi Sameshima
Tsuyomu Ikenoue
Ichiro Yasuhi
Tatsuhiko Kawarabayashi
author_facet Yasuyuki Kawagoe
Hiroshi Sameshima
Tsuyomu Ikenoue
Ichiro Yasuhi
Tatsuhiko Kawarabayashi
author_sort Yasuyuki Kawagoe
collection DOAJ
description Objectives. We evaluated the efficacy of magnesium sulfate as a second-line tocolysis for 48 hours. Materials and Methods. A multi-institutional, simple 2-arm randomized controlled trial was performed. Forty-five women at 22 to 34 weeks of gestation were eligible, whose ritodrine did not sufficiently inhibit uterine contractions. After excluding 12 women, 33 were randomly assigned to either magnesium alone or combination (ritodrine and magnesium). The treatment was determined as effective if the frequency of uterine contraction was reduced by 30% at 48 hours of the treatment. Results. After magnesium sulfate infusion, 90% prolonged their pregnancy for >48 hours. Combination therapy was effective in 95% (18/19), which was significantly higher than 50% (7/14) for magnesium alone. Conclusion. This randomized trial revealed that combination therapy significantly reduced uterine contractions, suggesting that adjuvant magnesium with ritodrine is recommended, rather than changing into magnesium alone, when uterine contractions are intractable with ritodrine infusion.
format Article
id doaj-art-894539b9d3dd487990e97b226d92d121
institution Kabale University
issn 2090-2727
2090-2735
language English
publishDate 2011-01-01
publisher Wiley
record_format Article
series Journal of Pregnancy
spelling doaj-art-894539b9d3dd487990e97b226d92d1212025-02-03T05:47:50ZengWileyJournal of Pregnancy2090-27272090-27352011-01-01201110.1155/2011/965060965060Magnesium Sulfate as a Second-Line Tocolytic Agent for Preterm Labor: A Randomized Controlled Trial in Kyushu IslandYasuyuki Kawagoe0Hiroshi Sameshima1Tsuyomu Ikenoue2Ichiro Yasuhi3Tatsuhiko Kawarabayashi4Department of Obstetrics and Gynecology, University of Miyazaki, 5200 Kihara, Kiyotake, Miyazaki 889-1692, JapanDepartment of Obstetrics and Gynecology, University of Miyazaki, 5200 Kihara, Kiyotake, Miyazaki 889-1692, JapanDepartment of Obstetrics and Gynecology, University of Miyazaki, 5200 Kihara, Kiyotake, Miyazaki 889-1692, JapanDepartment of Obstetrics and Gynecology, National Hospital Organization Nagasaki Medical Center, Nagasaki 856-8562, JapanDepartment of Obstetrics and Gynecology, Fukuoka University, Fukuoka 814-0180, JapanObjectives. We evaluated the efficacy of magnesium sulfate as a second-line tocolysis for 48 hours. Materials and Methods. A multi-institutional, simple 2-arm randomized controlled trial was performed. Forty-five women at 22 to 34 weeks of gestation were eligible, whose ritodrine did not sufficiently inhibit uterine contractions. After excluding 12 women, 33 were randomly assigned to either magnesium alone or combination (ritodrine and magnesium). The treatment was determined as effective if the frequency of uterine contraction was reduced by 30% at 48 hours of the treatment. Results. After magnesium sulfate infusion, 90% prolonged their pregnancy for >48 hours. Combination therapy was effective in 95% (18/19), which was significantly higher than 50% (7/14) for magnesium alone. Conclusion. This randomized trial revealed that combination therapy significantly reduced uterine contractions, suggesting that adjuvant magnesium with ritodrine is recommended, rather than changing into magnesium alone, when uterine contractions are intractable with ritodrine infusion.http://dx.doi.org/10.1155/2011/965060
spellingShingle Yasuyuki Kawagoe
Hiroshi Sameshima
Tsuyomu Ikenoue
Ichiro Yasuhi
Tatsuhiko Kawarabayashi
Magnesium Sulfate as a Second-Line Tocolytic Agent for Preterm Labor: A Randomized Controlled Trial in Kyushu Island
Journal of Pregnancy
title Magnesium Sulfate as a Second-Line Tocolytic Agent for Preterm Labor: A Randomized Controlled Trial in Kyushu Island
title_full Magnesium Sulfate as a Second-Line Tocolytic Agent for Preterm Labor: A Randomized Controlled Trial in Kyushu Island
title_fullStr Magnesium Sulfate as a Second-Line Tocolytic Agent for Preterm Labor: A Randomized Controlled Trial in Kyushu Island
title_full_unstemmed Magnesium Sulfate as a Second-Line Tocolytic Agent for Preterm Labor: A Randomized Controlled Trial in Kyushu Island
title_short Magnesium Sulfate as a Second-Line Tocolytic Agent for Preterm Labor: A Randomized Controlled Trial in Kyushu Island
title_sort magnesium sulfate as a second line tocolytic agent for preterm labor a randomized controlled trial in kyushu island
url http://dx.doi.org/10.1155/2011/965060
work_keys_str_mv AT yasuyukikawagoe magnesiumsulfateasasecondlinetocolyticagentforpretermlaborarandomizedcontrolledtrialinkyushuisland
AT hiroshisameshima magnesiumsulfateasasecondlinetocolyticagentforpretermlaborarandomizedcontrolledtrialinkyushuisland
AT tsuyomuikenoue magnesiumsulfateasasecondlinetocolyticagentforpretermlaborarandomizedcontrolledtrialinkyushuisland
AT ichiroyasuhi magnesiumsulfateasasecondlinetocolyticagentforpretermlaborarandomizedcontrolledtrialinkyushuisland
AT tatsuhikokawarabayashi magnesiumsulfateasasecondlinetocolyticagentforpretermlaborarandomizedcontrolledtrialinkyushuisland